Pierre Larrieu

1.6k total citations
16 papers, 1.3k citations indexed

About

Pierre Larrieu is a scholar working on Molecular Biology, Biological Psychiatry and Immunology. According to data from OpenAlex, Pierre Larrieu has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Biological Psychiatry and 7 papers in Immunology. Recurrent topics in Pierre Larrieu's work include Tryptophan and brain disorders (8 papers), Immunotherapy and Immune Responses (5 papers) and Stress Responses and Cortisol (3 papers). Pierre Larrieu is often cited by papers focused on Tryptophan and brain disorders (8 papers), Immunotherapy and Immune Responses (5 papers) and Stress Responses and Cortisol (3 papers). Pierre Larrieu collaborates with scholars based in France, Belgium and United States. Pierre Larrieu's co-authors include Luc Pilotte, Benoı̂t J. Van den Eynde, Vincent Stroobant, Didier Colau, Eduard Dolušić, Johan Wouters, Raphaël Frédérick, Bernard Masereel, Catherine Uyttenhove and Etienne De Plaen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Pierre Larrieu

15 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Larrieu France 11 726 535 362 288 221 16 1.3k
William P. Malachowski United States 19 740 1.0× 714 1.3× 382 1.1× 320 1.1× 287 1.3× 34 1.8k
Dipanwita Batabyal United States 14 386 0.5× 438 0.8× 68 0.2× 156 0.5× 59 0.3× 26 862
Iris Grossman Israel 23 68 0.1× 594 1.1× 155 0.4× 144 0.5× 83 0.4× 43 1.4k
Wuyan Chen China 26 44 0.1× 1.1k 2.0× 48 0.1× 31 0.1× 64 0.3× 42 1.5k
Pavitra Kannan United States 18 31 0.0× 404 0.8× 40 0.1× 128 0.4× 517 2.3× 33 1.2k
Bahman M. Sadeghpour Italy 12 101 0.1× 177 0.3× 13 0.0× 36 0.1× 504 2.3× 18 917
Terence G. Hamill United States 21 36 0.0× 616 1.2× 64 0.2× 51 0.2× 54 0.2× 50 1.4k
Shane M. Wilkinson Australia 18 46 0.1× 456 0.9× 99 0.3× 37 0.1× 106 0.5× 26 1.3k
Tadayuki Takashima Japan 24 31 0.0× 257 0.5× 23 0.1× 63 0.2× 473 2.1× 39 1.1k
Nobuki Nengaki Japan 18 36 0.0× 396 0.7× 55 0.2× 52 0.2× 198 0.9× 76 985

Countries citing papers authored by Pierre Larrieu

Since Specialization
Citations

This map shows the geographic impact of Pierre Larrieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Larrieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Larrieu more than expected).

Fields of papers citing papers by Pierre Larrieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Larrieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Larrieu. The network helps show where Pierre Larrieu may publish in the future.

Co-authorship network of co-authors of Pierre Larrieu

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Larrieu. A scholar is included among the top collaborators of Pierre Larrieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Larrieu. Pierre Larrieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Théate, Ivan, Nicolas van Baren, Luc Pilotte, et al.. (2014). Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues. Cancer Immunology Research. 3(2). 161–172. 284 indexed citations
2.
Larrieu, Pierre, Vincent Stroobant, Jean‐François Fonteneau, et al.. (2014). A Spliced Antigenic Peptide Comprising a Single Spliced Amino Acid Is Produced in the Proteasome by Reverse Splicing of a Longer Peptide Fragment followed by Trimming. The Journal of Immunology. 192(4). 1962–1971. 58 indexed citations
3.
Dolušić, Eduard, Pierre Larrieu, Arnaud Rives, et al.. (2012). Indoleamine 2,3-dioxygenase inhibitory activity of derivatives of marine alkaloid tsitsikammamine A. Bioorganic & Medicinal Chemistry Letters. 23(1). 47–54. 27 indexed citations
4.
Chauvin, Joë-Marc, Pierre Larrieu, Guillaume Sarrabayrouse, et al.. (2012). HLA Anchor Optimization of the Melan-A–HLA-A2 Epitope within a Long Peptide Is Required for Efficient Cross-Priming of Human Tumor-Reactive T Cells. The Journal of Immunology. 188(5). 2102–2110. 22 indexed citations
5.
Pilotte, Luc, Pierre Larrieu, Vincent Stroobant, et al.. (2012). Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proceedings of the National Academy of Sciences. 109(7). 2497–2502. 473 indexed citations
6.
Dolušić, Eduard, Pierre Larrieu, Sébastien Blanc, et al.. (2011). Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors. European Journal of Medicinal Chemistry. 46(7). 3058–3065. 50 indexed citations
7.
Dolušić, Eduard, Pierre Larrieu, Vincent Stroobant, et al.. (2011). Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators. Journal of Medicinal Chemistry. 54(15). 5320–5334. 155 indexed citations
8.
Dolušić, Eduard, Pierre Larrieu, Sébastien Blanc, et al.. (2010). Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors. Bioorganic & Medicinal Chemistry. 19(4). 1550–1561. 34 indexed citations
9.
Godefroy, Emmanuelle, et al.. (2010). Folding of Matrix Metalloproteinase-2 Prevents Endogenous Generation of MHC Class-I Restricted Epitope. PLoS ONE. 5(7). e11894–e11894. 5 indexed citations
10.
Röhrig, Ute F., Aurélien Grosdidier, Pierre Larrieu, et al.. (2010). Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors. Journal of Medicinal Chemistry. 53(3). 1172–1189. 136 indexed citations
11.
Charlier, Caroline, Eduard Dolušić, Pierre Larrieu, et al.. (2010). Design, synthesis and study of inhibitors of tryptophan 2,3-dioxygenase (TDO), a promising target for cancer therapy. Repository of the University of Namur. 1 indexed citations
12.
Larrieu, Pierre, et al.. (2007). A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes. Cancer Immunology Immunotherapy. 57(5). 745–752. 6 indexed citations
13.
Larrieu, Pierre, Laure‐Hélène Ouisse, Yannick Guilloux, Francine Jotereau, & Jean‐François Fonteneau. (2007). A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+ T lymphocytes. Cancer Immunology Immunotherapy. 56(10). 1565–1575. 9 indexed citations
14.
Oruganti, Srinivas, Pierre Larrieu, Eric Duverger, et al.. (2007). Synthesis of Glycocluster−Tumor Antigenic Peptide Conjugates for Dendritic Cell Targeting. Bioconjugate Chemistry. 18(5). 1547–1554. 33 indexed citations
15.
Busto, J., D. Dassié, O. Helene, et al.. (1990). The 0+ → 2+ neutrinoless double beta decay of 76Ge: Results of the Frejus experiment. Nuclear Physics A. 513(2). 291–315. 13 indexed citations
16.
Hubert, Ph., D. Dassié, Pierre Larrieu, et al.. (1986). α-rays induced background in ultra low level counting with Ge spectrometers. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 252(1). 87–90. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William P. Malachowski Breakdown of academic impact, for papers by Dipanwita Batabyal Breakdown of academic impact, for papers by Iris Grossman Breakdown of academic impact, for papers by Wuyan Chen Breakdown of academic impact, for papers by Pavitra Kannan Breakdown of academic impact, for papers by Bahman M. Sadeghpour Breakdown of academic impact, for papers by Terence G. Hamill Breakdown of academic impact, for papers by Shane M. Wilkinson Breakdown of academic impact, for papers by Tadayuki Takashima Breakdown of academic impact, for papers by Nobuki Nengaki
Rankless by CCL
2026